GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Ligua 7090.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

855

+5.17%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥2.42bn

FY2018FY2026

Net income

−¥241.0m

FY2018FY2026

Free cash flow

¥253.6m

FY2018FY2026

Shareholders' equity

¥176.9m

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue¥2.42bn¥2.87bn¥3.43bn¥2.84bn¥3.20bn¥2.69bn¥2.17bn¥1.81bn¥1.47bn
Gross profit¥1.42bn¥1.71bn¥1.88bn¥1.22bn¥1.63bn¥1.44bn¥1.23bn¥1.05bn¥912.5m
Research and development——¥13.2m————¥8.0m—
Operating income−¥123.5m−¥159.2m¥118.3m−¥869.7m¥158.5m¥247.1m¥224.3m¥65.5m¥161.6m
Net income−¥241.0m−¥301.0m¥104.1m−¥774.5m¥72.4m¥157.2m¥142.7m¥35.6m¥73.7m
Diluted earnings per share-151.53-202.0869.85-526.1351.75109.6599.8322.3846.35

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets¥2.49bn¥3.14bn¥3.87bn¥3.37bn¥3.28bn¥3.32bn¥1.61bn¥912.0m¥707.4m
Cash and short-term investments¥1.19bn¥1.35bn¥1.33bn¥1.17bn¥1.38bn¥1.93bn¥942.2m¥288.4m¥226.6m
Total liabilities¥2.32bn¥2.82bn¥3.26bn¥3.02bn¥2.14bn¥2.26bn¥789.8m¥752.2m¥552.1m
Debt¥1.62bn¥2.10bn¥2.39bn¥2.26bn¥1.51bn¥1.67bn¥385.8m¥382.6m¥183.4m
Shareholders' equity¥176.9m¥319.8m¥604.9m¥353.2m¥1.14bn¥1.06bn¥822.1m¥159.8m¥155.2m
Shares outstanding2m1m1m1m1m1m1m2m2m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations¥263.7m¥163.4m¥2.8m−¥328.2m¥80.1m¥207.2m¥366.6m¥3.3m¥140.8m
Capital spending−¥10.1m−¥16.9m−¥8.0m−¥56.7m−¥39.9m−¥29.4m−¥11.2m−¥13.3m−¥38.0m
Free cash flow¥253.6m¥146.5m−¥5.2m−¥384.9m¥40.2m¥177.8m¥355.4m−¥10.1m¥102.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥638.9m¥678.5m¥449.4m¥623.9m¥667.4m¥649.3m¥708.7m¥711.1m
Gross profit¥367.8m¥405.0m¥229.7m¥365.9m¥422.2m¥404.4m¥395.8m¥424.5m
Operating income¥31.1m¥48.4m−¥136.4m−¥25.2m−¥10.3m−¥79.9m−¥30.9m−¥21.2m
Net income−¥9.4m−¥37.5m−¥152.4m¥14.3m−¥65.4m−¥164.0m−¥55.6m−¥34.0m
Diluted earnings per share-5.91-23.56-102.319.57-43.92-110.08-37.30-22.84
Total assets¥2.51bn¥2.49bn¥2.63bn¥2.79bn¥2.91bn¥3.14bn¥3.67bn¥3.80bn
Cash and short-term investments¥1.15bn¥1.19bn¥1.21bn¥1.18bn¥1.18bn¥1.35bn¥1.57bn¥1.66bn
Debt¥1.15bn¥1.62bn¥1.19bn¥1.82bn¥1.21bn¥2.10bn¥1.49bn¥2.43bn
Shareholders' equity¥167.4m¥176.9m¥123.0m¥272.9m¥254.4m¥319.8m¥483.8m¥539.4m

Financial ratios

Data as of 2 Nov 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2019
Gross margin58.8%59.4%54.8%43.2%51.0%53.7%—
Operating margin-5.1%-5.5%3.4%-17.9%4.9%9.2%—
Net margin-10.0%-10.5%3.0%-27.3%2.3%5.9%—
Return on equity-136.3%-94.1%17.2%-219.3%6.3%14.9%—
Return on assets-9.7%-9.6%2.7%-23.0%2.2%4.7%—
Free cash flow yield19.1%13.5%0.8%-20.5%9.5%18.4%—
Revenue growth-15.8%-16.3%20.9%-11.4%19.2%24.0%—
Earnings growth-19.9%-389.2%-113.4%-1169.6%-54.0%10.2%—
Current ratio1.25x1.34x1.26x1.31x2.04x2.39x—
Debt to equity9.16x6.57x3.95x6.40x1.32x1.58x—
Equity ratio7.1%10.2%15.6%10.5%34.9%31.9%—
Interest coverage-4.16x-5.51x5.61x-30.75x15.75x25.20x—
R&D as a share of sales——0.4%———0.4%
Buybacks as a share of market value-6.8%0.0%-1.2%-5.2%2.4%-0.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-5.2%-2.1%—
Operating income-47.8%——
Net income-32.2%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin59.1%53.9%53.3%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-5.4-4.512.2-2.421.931.133.4
Price to sales0.50.50.40.70.51.82.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.